Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The derivation of diagnostic markers of chronic myeloid leukemia progression from microarray data

5 Aug 2009

Abstract excerpt

Currently, limited molecular markers exist that can determine where in the spectrum of chronic myeloid leukemia (CML) progression an individual patient falls at diagnosis. Gene expression profiles can predict disease and prognosis, but most widely used microarray analytical methods yield lengthy gene candidate lists that are difficult to apply clinically. Consequently, we applied a probabilistic method called...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Lymphocytic Leukemia Research
Share to Chronic Myeloid Leukemia Treatments
Share to Lymphoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19654405
DOI: 10.1182/blood-2009-03-212969

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The derivation of diagnostic markers of chronic myeloid leukemia progression from microarray dataPMID 19654405Read ↗

Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome predictionSemantic proximity Read ↗

Integrating genetic and epigenetic factors in chronic myeloid leukemia risk assessment: toward gene expression-based biomarkersSemantic proximity Read ↗

Single-cell transcriptomics-guided development of flow cytometric tests predicting chronic myeloid leukemia blast crisis transformation at chronic phase diagnosisSemantic proximity Read ↗

Molecular subtypes predict therapeutic responses and identifying and validating diagnostic signatures based on machine learning in chronic myeloid leukemiaSemantic proximity Read ↗

BAMBI: Integrative <i>b</i> iostatistical and <i>a</i> rtificial-intelligence <i>m</i> odels discover coding and non-coding RNA genes as <i>bi</i> omarkersSemantic proximity Read ↗

Single cell guided deconvolution of bulk transcriptomics recapitulates differentiation stages of acute myeloid leukemia and predicts drug responseSemantic proximity Read ↗

A transcriptomic based deconvolution framework for assessing differentiation stages and drug responses of AMLSemantic proximity Read ↗

Baseline Acute Myeloid Leukemia Prognosis Models using Transcriptomic and Clinical Profiles by Studying the Impacts of Dimensionality Reductions and Gene Signatures on Cox-Proportional HazardSemantic proximity Read ↗

Prediction of therapy outcomes of CLL using gene expression intensity, clustering, and ANN classification of single cell transcriptomesSemantic proximity Read ↗

State-Transition Analysis of Time-Sequential Gene Expression Identifies Critical Points That Predict Development of Acute Myeloid LeukemiaSemantic proximity Read ↗

State-transition modeling of blood transcriptome predicts disease evolution and treatment response in chronic myeloid leukemiaSemantic proximity Read ↗

Bayesian Variable Selection For High-Dimensional Data With An Ordinal Response: Application Predicting Prognostic Risk Group In Acute Myeloid LeukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.